Annual Review of Cancer Biology

Papers
(The H4-Index of Annual Review of Cancer Biology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Immune Cell Metabolism and Immuno-Oncology107
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo40
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer35
lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy Resistance35
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond32
Lessons from 3D Reconstruction of Cancer32
Mitochondria, OXPHOS, and Cancer Progression: A Modular View27
Natural and Engineered Cytokines as Cancer Therapeutics22
Allogeneic CAR T Cell Therapy for Cancer21
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?20
Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer Biology19
They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer Immunity16
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies15
Cancer Dependency Map: Past and Present15
Road Map to Defeat Pancreatic Cancer15
Cancer Cell Polarity and Extrusion15
0.1565568447113